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Breast Cancer Research was launched in 1999 with the aim
of providing a home for translational research in breast
cancer [1]. The field of translational research has advanced
considerably over the past ten years, and the journal has
evolved over this time to meet the changing needs of the
breast cancer research community. As we celebrate Breast
Cancer Research’s 10th birthday, we take this opportunity to
reflect on the journal’s growth over the last decade.
Breast Cancer Research is committed to open access
publication of research articles, and remains the only journal
in the breast cancer field dedicated to open access. Open
access means research is universally and freely available via
the Internet. Authors retain their own copyright, allowing them
to grant any third party the right to use, reproduce and
disseminate the article. Open access has broad benefits both
for scientists and the general public. Anyone with an Internet
connection is able to read the research for free without
having to rely on access to a library with a subscription. For
example, the 2006 paper by Scutt et al. [2] received wide
coverage [3] and was instantly available for any interested
patients or clinicians - something that is much more difficult
for articles published in subscription based journals.
Over the last ten years, there have been massive leaps
forward in open access publishing. Many more journals now
offer open access options, and there is more support for this
publishing model within the scientific community. In particular,
many funders now advocate open access by making it a
condition of funding that a version of the accepted article is
made available in a public repository such as PubMed Central.
A recent exciting development has been the announcement of
the National Institutes of Health (NIH) Public Access Policy
[4], which comes into place in April this year.
Open access allows our research to be accessible to a vast
potential audience, with over 80,000 articles downloaded
from our website every month. Indeed, our most highly
accessed article from Arpino and colleagues [5] has been
downloaded over 35,000 times since publication. Our highly
visible research is complemented by educational reviews and
timely opinion pieces. The type of articles published has
changed over the years, expanding in 2003 to encompass
endocrinology [6], and adding new sections such as clinical
trial updates [7].
Breast Cancer Research has always aimed to make the most
of the advantages available online over the traditional print
format, and in 2005 the print version of the journal was
discontinued. This reflects a general publishing trend away
from print in the way readers now find articles of interest. The
journal’s online functionality means you can search PubMed
or Google Scholar for related articles, post and read
comments, email articles to colleagues and even post articles
directly to social networking sites such as Facebook. In the
pipeline are online tools for our referees, and a revamped
design for the homepage, which will give the website a
cleaner, easy-to-navigate new look.
In addition to developing online functionality, the journal has
always strived to provide access to the latest research as
quickly as possible. Our average time from submission to
giving authors a first decision is less than 6 weeks, and for
the past year we have published all research articles as
soon as they are accepted. Articles now have their final
citation and are listed in PubMed on the day they are
accepted – a service unique to Breast Cancer Research
amongst our competitor breast cancer journals. All our
research articles are immediately archived in repositories
such as PubMed Central to ensure that our articles will be
permanently available.
Of course, one measure of a journal’s success that is highly
valued amongst our authors and readers is that of the Impact
Factor.  Breast Cancer Research currently has an impact
factor of 4.16, ranking us the second most cited breast cancer
journal, according to the 2006 Journal Citation Report [8].
Breast Cancer Research also compares very favourably using
the new SCImago Journal Rank [9]. SCImago takes into
account the citation record of the journal you are being cited
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by and ranks Breast Cancer Research 26th out of all 139
oncology journals, an impressive placing for a niche journal.
Breast Cancer Research has had a very impressive first ten
years. As we celebrate the journal’s continued growth, we
would like to thank our Editorial Board for their ongoing
support, as well as our authors and reviewers who all
contribute to the journal’s success. We hope to continue to
evolve, and look forward to the journal’s progress over the
next decade!
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